Atorvastatin Calcium Tablets — Class II drug recall D-0832-2020
Terminated recall by Graviti Pharmaceuticals Private Limited, reported 2020-02-12, distributed nationwide. Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was presen
| Recall number | D-0832-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Graviti Pharmaceuticals Private Limited, Medak, N/A, India |
| Recall initiated | 2020-01-28 |
| Classified | 2020-02-07 |
| Reported by FDA | 2020-02-12 |
| Terminated | 2022-11-29 |
| Distributed | Nationwide (US) |
| Quantity | 29,056 bottles |
| Reason classes | labeling |
| NDC | 70377-0027-11 |
| Lot numbers | ATA318099C |
| Expiration dates | 2020-12 |
Product
Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0832-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.